Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.980
-0.080 (-1.97%)
At close: Nov 13, 2026, 4:00 PM EST
4.095
+0.115 (2.89%)
After-hours: Nov 13, 2026, 5:59 PM EST
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $384.68 million as of November 13, 2026. It is the 16,205th most valuable company in the world and the 2,911th biggest in the United States. Its market cap has increased by 190.52% in one year.
Market Cap
384.68M
Enterprise Value
331.59M
1-Year Change
190.52%
Global Rank
Country Rank
#2,911 United States
Category
ChartMarket Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $384.68M, an increase of 1,709.21%. That is a compound annual growth rate of 61.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 384.68M | 177.51% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 411.32M |
| Assembly Biosciences | 410.88M |
| Rezolute | 405.98M |
| Aspen Neuroscience | 395.76M |
| MapLight Therapeutics | 392.92M |
| CorMedix | 384.96M |
| Lyell Immunopharma | 384.52M |
| Contineum Therapeutics | 384.02M |